Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study

Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study

BackgroundWe compared the real-world efficacy and safety of neoadjuvant chemoimmunotherapy to chemotherapy alone in patients with stage III non-small-cell lung cancer (NSCLC).Participants and methodsA total of 59 consecutive patients were finally selected and divided into two groups: the neoadjuvant...

Full description

Bibliographic Details
Main Authors: Sihao Zhou, Yi Liu, Kejun Liu, Junkai Zhang, Hanlin Liang, Yingmeng Wu, Hongyu Ye, Yi Liang, Jingjing Zhang, Weizhao Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
non-small-cell lung cancer
neoadjuvant therapy
chemotherapy
immunotherapy
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1343504/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1343504/full

Similar Items